Abivax SA ABVX.PA FR Equity
Abivax SA (Euronext Paris: ABVX.PA) closed at €99.95, -0.4%, on 2026-08-27, with a market cap of $8.1B as of 2026-08-26, a return on equity of -135.6%, a net margin of -7354.5% and 3-year sales growth of -0.1%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14· ABVXAbivax S.A.
6 settlement cyclesShort interest shown for the US-listed sibling ABVX — FINRA covers US listings; figures are that line's shares.
| Shares short | 6.0M |
| % of shares out | — |
| Days to cover | 7.8 |
| Δ vs 2026-07-31 | +15.5% |
bars = shares short · line = days to cover (own scale)
% of shares outstanding suppressed: the listed line's share basis (ADR/depositary) differs from the reported ordinary share count.
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.